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The  isolation  of  an  unidentified  transmissible  cytopathic  agent,  possibly 
from the acute phase blood of an infectious hepatitis patient, has been reported 
(1).  This  agent  possesses  an  unique  property  of  inducing  active  DNA  and 
thymine  catabolism  in infected  "liver"  cells  (2).  Until  recently,  characteriza- 
tion of the agent was greatly hampered by its existence in cell-associated form 
(1).  Our recent  success in obtaining  it in cell-free form has greatly facilitated 
the  characterization  of  this  transmissible  agent.  This  report  describes  its 
biological,  immunological,  and  physicochemical  properties.  Since  some of the 
properties are sufficiently unique,  the possibility of a  new class of transmissible 
agent should be considered. The release of a  lipogenic toxin and the mechanism 
of DNA  and thymine  degradation  are described  in the  accompanying reports 
(3, 4). A study of the cytopathology of this agent using the electron microscope 
is in progress? 
Materials and Methods 
Nutrie,~ Media.--Unless  spedfied otherwise, the medium consisted of 5 per cent inactivated 
horse serum in Eagle's basal medium (5) as modified in our laboratory for the cultivation of 
primary human  amnion  cells  (6).  Holmes' chemically  defined  medium  (7)  was simplified 
through the elimination  of the coenzymes and the nucleotides. This simplification  did not de- 
tectably affect its ability to sustain the growth of an adapted strain of human "liver" cells. 
This simplified Holmes' medium consisted of Eagle's basal medium, as modified for the primary 
amnion cells, and the following additional  compounds  (in mg per liter): L-cysteine HC1 75, 
reduced glutathione 15, ascorbic acid 17, alpha-amino-,-butyric acid 2.5, L-omithine HCI 3.5, 
L-taurine  2, L-homocystine  1, L-ergothione-HCI.H20 1, D-glucosamine HCI 3.2, glucurono- 
lactone 1, Na glucuronate  1, glucose-l-phosphate 1, citric acid 1, Na acetate .3 H20 83, L-hy- 
droxyproline  20, p-aminobenzoic  acid 0.05, alpha-tocopherol  phosphate 0.01, biotin 1, thiotic 
acid  1.5, adenosine-S-phosphate  0.02, D-ribose 0.23, D-2-deoxyribose 0.2,  vitamin B12  2.5, 
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cholesterol 0.2,  menadione 0.01,  calciferol 0.1,  vitamin A  0.1,  beta estradiol 0.1,  and tween 
80 5. 
Cell Cultures.--Ali cell cultures were grown on glass as monolayers. The tubes were revolved 
at 12 revolutions per hour in a 36°C incubator. Unless specified otherwise, an established strain 
of epithelial-like cell derived from an explant of human liver was used exclusively (8).  This 
culture has been propagated in our laboratory since its original isolation without any animal 
passage. 
Propagation of this Transmissible Agent.--The history of this agent has already been de- 
scribed (1).  Infected "liver"  cultures which showed complete Cell destruction were found to 
retain infectivity for at least 10 months when stored at 0-4°C; these cultures served as con- 
venient sources of this agent. To prepare the cell-free form, "liver" cultures nourished in the 
simplified Holmes' medium were used. After infected cultures showed complete degeneration, 
they were kept at 36°C for 3 additional days. The media were pooled and centrifuged at 2000 
gP~ for 15 minutes in a horizontal International centrifuge. The upper a~ of this supernatant 
fluid was collected. Since this fluid was low in infectivity (containing about i0 infectious doses 
per ml) and contained interferon-like substance as well as a lipogenic toxin (3), it was further 
centrifuged at 14,000 RP~ for 1 hour in a  Servall SS-1 angle head centrifuge. The sediment, 
which  contained  the  infectivity,  was  resuspended  in  ~0  its  original  volume  of  simpli- 
fied Holmes' medium. This concentrated preparation was kept at 0-4°C and may be used for 
several months. The supernatant fluid which was not infectious, contained the lipogenic toxin 
to be elaborated upon in the accompanying report (3). In 3 recent experiments, the cell-free 
form was also obtained from infected "liver," primary amnion, and chick embryonic tissue 
cultures which were nourished in Eagle's basal medium containing 5 per cent horse serum. The 
results reported in this manuscript are based on study with this agent, which has undergone 
numerous passages in the "liver" culture since its original isolation in 1954. 
Virus Titration.--The  standard tube dilution technic was used. Serial two-, four-, or ten- 
fold dilutions of the preparation were made; and 2 to 4 liver cultures were used for each dilu- 
tion. The appearance of cytopathic changes was recorded.  Cultures showing no cytopathic 
changes after 3 weeks were discarded as negative. 
Neutralization.--The  standard tube neutralization test was used. 0.25 ml of a preparation 
of this agent was mixed with 0.25 ml of serum. The mixture was stored at 0--4°C for 16 to 20 
hours. 0.4 ml of this mixture was then inoculated in a "liver" culture. This amount of inoculum 
contained approximately 10 infectious doses. 3 control cultures receiving the same amount of 
this agent were included in each test.  3  days after the appearance of advanced cytopathic 
changes in these 3 control cultures, the test was read. Those showing no cytopathic changes 
were considered positive for antibody or inhibitor. All serums were tested undiluted and at 
dilution of ~, ~,  and occasionally ~4. When the quantity was insufficient, the specimen was 
tested at ~, ~6, and Ha. In the later portion of this study, serums were frequently surveyed 
for heat-stable antibody without dilution. For the detection of heat-stable antibody, serums 
were routinely heated at 56°C for 30 minutes prior to testing. In the titration of heat-labile 
inhibitor, this preheating was omitted. 
Other Viruses.--Stock  preparations of adeno 3 and polio 1 viruses were propagated in cul- 
tures of HeLa cells (9); Coxsackie B 1 and herpes simplex in "liver" cells, and vaccinia virus, on 
chorioallantoic membranes of chick embryos. 
Enzymatic Digestion.--All enzymatic digestions (other than those involving the use of lipo- 
lyric enzymes) were carried out by diluting the enzymes in Eagle's basal medium (pH 7.4-7.8), 
mixing equal portions of diluted enzymes and a preparation of this agent, incubating the mix- 
ture at 37°C for 20 hours, and then testing for infectivity in "liver" cultures. The final con- 
centrations of the enzymes varied from 50 to 200/Lg per ml. In experiments using trypsin, 
about 300/~g of crystalline soybean trypsin inhibitor were added prior to the transfer of tryp- 
sin-contalning materials  to  "liver"  cultures.  Due  to  non-specific  degeneration  caused  by R.  SHIIIMAN  CHANG  AND  MARYELLEN  HU'MES  939 
papain, a blind passage of the cell sediment  was routinely  made 2 days following  the introduc- 
tion of materials  containing  papain. 
EXPE]~MENTAL RESULTS 
1.  Cytopathology 
5 to 7 days following inoculation with 10 infectious doses, the "fiver" culture 
showed characteristic degenerative changes. These changes progressed rapidly 
involving all cells within 2 to 3 days. These cellular changes consisted of granu- 
larity, crenation, and loss of structural distinction between nucleus and cyto- 
plasm (see Fig. 1). In preparations stained with hemotoxylin-eosin, intranuclear 
changes were characteristic. The nuclear changes consisted of condensation of 
basophilic materials along the nuclear membrane and the formation of baso- 
philic globules of varying number and sizes (see Fig. 2 A). With further changes, 
the involved nucleus apparently collapsed and appeared as a  small basophilic 
mass without structural detail  (Fig.  2 B).  In culture  showing advanced de- 
generation,  many cells  consisted of cytoplasmic masses in which were  situ- 
ated a  basophilic globule and a  basophilic ring surrounding a  basophilic dot 
(Fig. 2 C). In the end stage, the basophilic globule was no longer visible and 
the cytoplasm became more vacuolated (Fig. 2 D).  Further disintegration of 
such shrunken cells occurred at a very slow pace; 1 month (at 37°C) after com- 
plete degeneration, numerous shrunken cells  still remained.  Feulgen staining 
showed that the abnormal basophilic masses and globules, illustrated in Fig. 2, 
were Feulgen-positive (DNA).  The basophilic ring was also Feulgen-positive; 
the  central basophilic dot was  Feulgen-negative  (nucleolus?), however.  The 
condensation of basophilic materials along the  nuclear membrane was  also 
seen  occasionally  in  presumably  uninfected  "liver"  and  primary  amnion 
cultures. 
In our eariler study with the cell-associated forms (1), it was described  that 
the infecting process may at times show 3 other features: 1, marked prolonga- 
tion of the incubation period; 2, establishment of a  "chronic" infection, and, 
3, reappearance of colonies of healthy cells in apparently completely degener- 
ated cultures. Such variations in the infecting process have not been encoun- 
tered in "liver" cultures infected with the cell-free  form. 
2.  Susceptibility  of different  types of cells in vitro 
The reaction of primary human amnion cells was distinctly different from 
that of the "liver" cells. Seven lots of amnion cells each harvested from a single 
placenta had been studied thus far. Six of the seven failed to show character- 
istic progressive degeneration after inoculation with 3 to 300 infectious doses. 
Transient cytoplasmic granularity and non-progressive cell  destruction were 
noted at irregular intervals. Infectious materials were being released from such 
amnion cultures (some for over 3 months) as demonstrated by the transfer of 940  CULTURED  HUMAN  CELLS 
uncentrifuged used  media  to  "liver" cultures;  the  recipient  "liver" cultures 
invariably showed characteristic cytopathic changes. An exception was noted, 
however.  One  lot  of primary amnion  cells  was  completely destroyed about 
15 days following infection with about 300 infectious doses. Four lots of primary 
human embryonic skin and muscles from 3 to 4-month-old embryos, one lot of 
primary monkey-kidney cells,  three lots of primary embryonic chick tissue, 
the HeLa (9), conjunctival (8), FL (10), KB  (11), mouse fibroblast strain L 
(12), and sarcoma  180  II  (13)  cells  were completely destroyed 4  to  10 days 
after infection with about 10 to 100 infectious doses. Two lots of mouse embryo 
cultures were also destroyed in about 14 days. Of some interest was an observa- 
tion that the ribose variants derived from the HeLa and the conjunctival cells 
(14)  were much less susceptible than the parent cultures; the ribose variants 
also multiplied at slower rates as compared to the parent cultures. 
3.  The production of interferons 
The appearance of "chronic" infections in primary amnion cultures suggested 
that interferon-like substances may be released by the infected cells. The fluid 
phase of infected liver and primary amnion cultures, after removal of infectious 
particles by centrifugation at  14,000  RI,~  (SS1  Servall), were tested at final 
concentration of 30 per cent by a method currently used (15). The appearance 
of cytopathic changes  in  the  liver  or  primary amnion  infected with  about 
30 ID of Coxsackie B1 virus was significantly and regularly delayed. Such delay 
was not observed, however, in liver cultures infected with poliovirus type 1 or 
with this agent (30 ID used). It seemed reasonable to conclude that interferon- 
like activity was released from the infected cells. There was no evidence, how- 
ever, that the interferon released was  responsible for the "chronic" infection 
observed in the primary amnion cultures. 
4. Stability  of its infectious property 
Thermostability.--At  0-4°C, this agent retained its infectivity for more than 
6 months.  At  37°C,  a  detectable reduction  of infectivity (as judged by the 
prolongation of the interval between infection and degeneration) was noted on 
the 14th and 35th day, and a  complete loss on the 70th day. At 56°C  for 30 
minutes, 5 out of 7 pools retained  partially  their infectivity. At 60°C for 30 
minutes, infectivity was detectable in 2 of 3 pools. At below---60°C, 1 pool was 
found infectious after 1 month but non-infectious after 6 months; a  2nd pool, 
with about 10  ~ infectious doses per ml before freezing, lost its infectivity after 
1 month. After 5 cycles of freeze-thawing by alternate immersion in dry ice- 
alcohol and 37°C  water  baths, 3 of 5 preparations  (infectious at dilution of 
1/64 or more)  became non-infectious when tested undiluted, while two were 
infectious at dilution of 1/4 but not at  1/8. R.  SHIHM.AN  CHANG  AND  MARYELLEN  HUM~S  941 
Inactivation by Ether and Chloroform.--Four  lots of this agent were extracted 
once with equal portions of ether; infectivity was no longer demonstrable in 
the aqueous phase. Similarly, extraction with chloroform inactivated this agent. 
Inactivation by Bile Salts.--When incubated with equal volume of 1 per cent 
sodium deoxycholate at 37°C for 2 hours, infectivity was partially reduced. 
Insusceptibility  to  Various  Proteases, Nucleases,  and  Carbohydrases.--The 
following enzymes had been tested and found ineffective in inactivating this 
agent: crystalline DNAse,  crystalline RNAse, crystalline  trypsin, crystalline 
papain,  crude trypsin, crude pancreafin,  crystalline eggwhite lysozyme, and 
bovine  testicular  hyaluronidase.  In  1  experiment  higher  concentrations  of 
DNAse, RNAse, or trypsin (0.5 to 1 mg per ml) were used; pH were adjusted 
to 6-7  for DNAse,  4.5-5  for RNAse, and 7.6-8.2  for trypsin; and digestion 
period was prolonged to 6 days at 36°C. Fresh enzymes were also added on the 
3rd and 5th days. Again, no significant reduction in infectivity was detected. 
Insusceptibility  to Pancreatic Lipase  and  Lecithinase.--ExamJnation  of the 
effect of lipolytic enzymes on the infectivity of this agent was complicated by 
the necessity of introducing bile  salts or ether into the reacting systems to 
bring about the optimal interactions of  the  enzymes and the lipids (16,  17). 
Both bile salts and ether have already been shown to destroy its infectivity. The 
effect of these 2 lipolytic enzymes were therefore tested without bile salts or 
ether in the reacting systems as follows: 
1.  0.1  ml of virus preparation was mixed with 0.05  ml of pancreatic lipase 
(2 per cent suspension in 0.5 ~  tris buffered at pH 8), 0.05 m145 per cent CaC15, 
and 0.3 ml 0.5 ~  tris (pH 8).  Mter 1 hour at 37°C,  infectivity was titrated in 
"liver cultures." 
2.  0.1 ml of virus was mixed with 0.1 ml of snake venom (Crotalus adamanteus 
venom, kindly furnished by the laboratory of Dr. E. P. Kennedy) and 0.3  ml 
Eagle basal medium. This amount of snake venom was equivalent to about 
0.5 mg of dry venom. Infectivity was titered after 1 hour at 37°C. Since snake 
venom at this concentration was also destructive to the "liver" cells, passages 
were routinely made for culture destroyed with 24 hours after receiving the 
inoculi. 
Both lipolytic enzymes fail to reduce the infectivity of this agent. 
Slow Inactivation by Formalin.--Results of the inactivation of this agent by 
0.025 per cent formalin are shown in Table I; the rate of inactivation is very 
much slower than that of vaccinia and herpes viruses, or polio and vesicular 
stomafitis viruses. 
5. Filtration and centrifugation 
Membrane  filters  (Millipore)  retained  the  infectivity in  most  instances; 
5 filtrates through filters with 5# pore size (which allowed passage of Staphylo- 
coccus aureus) and 7 of 9 through 0.35 micron filter were found non-infectious. 942  CULTURED HUMAN CELLS 
2 filtrates (0.35 micron) were infectious; technical errors, however, could not be 
positively excluded. In a single trial, infectivity was retained by ultrafine glass 
filter. 
Infectivity was not sedimented by centrifugation at 2000 m~ for 15 minutes 
(International horizontal model) but was regularly sedimented at  14,000  RP~ 
for 1 hour (Servall SS-1 superspeed angle centrifuge). Only 1 of 12 supernatant 
fuids was found infectious. 
TABLE I 
The Inactivation of This Unidentified Agent, the Vaccinia and Herpes 
Simplex Viruses by Formalin*, 
Time 
hrs. 
o 
24 
48 
96 
The agent 
A  B 
1280  2560 
<80  80 
80  640? 
20  20 
Infectivity§ vaccinia 
<IO 
<1o 
<1o 
Hexes 
105 
<10 
<10 
<10 
* Formalin used at final concentration of 1/4000;  pH -- 7.2-7.6 and temperature of incu- 
bation, 37°C. 
:~ See  Symposium on Inactivation of Viruses (New  York Acad.  So.,  1960, 83,  513),  for 
data on other viruses. 
§ Expressed as infectious doses per ml (tested in liver cultures). 
6.  Suppression  of its synthesis by 5-fluorodeoxyuridine 
Since the type of nucleic acid present in a virus may be of value in its identi- 
fication, experiments were designed to determine whether this is a  DNA- or 
RNA-containing  agent.  Two preliminary attempts  were made  in  extracting 
infectious nucleic  acid  from  107  specifically involved  shrunken  "liver" cells 
by the phenol method (18, 19). Infectious nucleic acid was not obtained. 
Based  on  the  well  established  observations  that  5-fluorodeoxyuridine 
(FUDR)  suppressed the formation of DNA- but not RNA-containing viruses 
(20-24),  the effect of FUDR on the propagation of this transmissible agent was 
studied. 
Three replicate cultures of primary human amnion cells were nourished for 
7 days with a nutrient medium containing 1/zg FUDR per ml. Previous study 
showed that at this concentration of FUDR the primary amnion did not de- 
generate or multiply significantly for at least  14 days  (6). The media of the 
3 cultures were then changed to that containing no FUDR,  1/zg FUDR plus 
50/~g thymidylate, and 1 #g FUDR, and were infected with 10 infectious doses 
of this  transmissible  agent.  Nutrients  were renewed every 3  or 4  days with R.  S~iHMAN  CHANG AND  MARYELLEN HUM~S  943 
their respective media. The used media together with any detached cells were 
transferred to liver cultures which were then observed for evidence of character- 
istic degeneration. 
The results are shown in Table II; FUDR suppressed partially or completely 
the formation of this agent. Thymidylate, however, fails to effect regularly a 
complete reversal of this suppressive action of FUDR. Since this latter finding 
is  contrary  to  what  has been reported  for 2 other DNA-containing  viruses 
TABLE  H 
E.ff~ct of FUDR on the Formation  of this Transmissible  Agent in Primary 
Human Amnion Cell Culture 
Expt. 
Nutrient media* 
FIYDR  Thymidylate 
0  0 
1  0 
1  50 
0  0 
1  0 
1  50 
0  0 
1  0 
1  50 
0  0 
1  0 
1  50 
Infectivity in media  on day after infection 
+  (4) 
+  (8) 
+  (8) 
+  (7) 
+  (13) 
+  (10) 
+  (7) 
+  (14) 
+  (5)~t 
+  (3) 
+  (7) 
+  (7) 
+  (3) 
+  (3) 
+  (3) 
+  (lO) 
+  (2) 
+  (3) 
+  (7) 
-b  (6) 
+  (2) 
--I-  (11) 
* Regular medium containing FUDR or thymidylate  in #g per ml. 
Signifies the day of onset of characteristic degeneration in liver cultures. 
(20,  24),  the possibility that  the cell system used in these experiments may 
contribute  to  this  difference  was  explored.  Earlier  work  (6)  indicated  that 
the  relatively  dormant  primary  amnion  cells  differed  considerably in  their 
response to FUDR from the rapidly growing  transformed cells used by other 
investigators. The propagation of 3 DNA-containing viruses (vaccinia,  adeno 
3,  and  herpes  simplex)  and  of 2 RNA-containing  viruses  (polio  1 and  Cox- 
sackie B1)  was investigated  under  experimental  conditions  similar  to  those 
described for this transmissible agent. The results of 1 single experiment are 
presented in Table III; FUDR exerts no detectable effect on the propagation 
of the RNA-containing viruses--it suppresses partially  the multiplication  of 
the DNA-containing  viruses,  and  this  suppressive effect is reversed by thy- 
midylate. These findings  are in  complete agreement  with  those reported by 944  CULTURED  HUMAN  CELLS 
others  (20-24).  Based on these studies,  it seemed reasonable  to conclude that 
this  transmissible  agent contained DNA. We are unable,  however,  to account 
for the failure of thymidylate to reverse regularly and completely the suppres- 
sive action of FUDR. 
TABLE III 
Effect of FUDR, with or without  Thymidylate,  on the Formation  of Several DNA- and 
RNA-Containing  Viruses  in Primary Human Amnion Cultures 
?olio 1 
Virus* 
~'oxsackie B1 
7accinia 
Herpes simplex 
~kdeno 3 
Degree of degeneration§ on 
Nutrient  media~ 
2  3  4  5  Titerf[  day, 
Control  + +  + + +  6.7 
FUDR  ++  +++  6.7 
FUDR, thymidylate  ++  +++  6.3 
Control  0  +  + + +  6.7 
FUDR  0  +  +++  6.7 
FUDR, thymidylate  0  +  + + +  7.0 
Control  0  +  ++  +++  4.5 
FUDR  0  0  +  +  2.7 
FUDR, thymidylate  0  +  ++  +++  4.5 
Control  + + +  4.5 
FUDR  +  3.0 
FUDR, thymidylate  + + +  4.3 
day, 5  7  10  15 
Control  0  +  +  + + +  5.5 
FUDR  0  0  0  +  3.5 
FUDR, thymidylate  0  +  +  + +  5.7 
* About 30 to 300 I.Vs0  were used. 
FUDR and thymidylate at 1 and 50 #g per ml medium, respectively. 
§ 0,  +, ++,  and +++  represented  no, early,  advanced,  and complete degeneration, 
respectively. 
[I Virus titer determined at the time when the control culture  (without  FUDR) showed 
complete degeneration; expressed as the negative logarithm of the high dilution which gave 
rise to cytopathic changes in 50 per cent of the inoculated cultures. 
The inability of thymidylate to reverse completely the suppressive action of 
FUDR on DNA or viral synthesis has been reported  (24,  25); reversals  were 
accomplished,  however,  by further  addition  of uridine  or uracil.  The appear- 
ance of characteristic cytopathic changes and the formation of infectious mate- 
rials were studied with liver and conjunctival cells treated with FUDR, FUDR 
plus  thymidine,  FUDR  plus  thymidine  and  uracil,  and  FUDR  plus  uracil. 
Results are shown in Table IV. Thymidine with or without uracil reverses the R.  SHIHM.AN CHANG AND MARYELLEN HUM~S  945 
cytotoxic  action  of  FUDR;  the  suppressive action  on  the  formation of  this 
agent was not affected, however. The possibility that FUDR may affect cellular 
metabolism by another mechanism as yet unknown should be considered. 
7.  Continued  release of infectivity from specifically involved shrunken cells 
Infectious materials were found to be released continually from specifically 
involved  shrunken  cells  for  many weeks  as  demonstrated  by  the  following 
TABLE  IV 
Failure of Thymidine  and Uracil to Reverse the Suppressive Effect of FUDR on the Formation 
of this Agent in Liver and Conjunc~ival Cells 
Cell  Media*  Multiplication index~:  Viral degeneration§ 
Liver 
Conjunctival 
Control 
FUDR 
FUDR, U 
FUDR, T 
FUDR, T, U 
Control 
FUDR 
FUDR, U 
FUDR, T 
FUDR, T, U 
1728/225 
218/225 
126/225 
1076/225 
1202/225 
1394/59 
32/59 
8/59 
772/59 
552/59 
6th day 
Neg. after 14 days 
Neg. after 14 days 
Neg. after 14 days 
Neg. after 14 days 
7th day 
Neg. after 14 days 
Neg. after 14 days 
Neg. after 14 days 
Neg. after 14 days 
* Regular medium to which FUDR, U (uracil), T  (thymidine) were added to concentra- 
tions of 1, 50, and 50 gg per ml, respectively. 
~t Multiplication of cells in uninfected culture; denominator =  No. of cell X  10' at 0 day 
and numerator, at 7th day. 
§ Extensive non-specific degenerations were noted  in  cultures treated  with  FUDR or 
FUDR plus uracil; these degenerative changes were not transmissible. 
experiment.  A  suspension of specifically involved shrunken  cells  (about  5  to 
10 million cells) was washed 3 times with 10 ml each of Eagle's basal medium by 
centrifugation at 2000 Rwa for 15 minutes; the washed sediment resuspended in 
2 ml of modified Holmes' medium was kept at 36°C for 7 to 34 days; the sus- 
pension was then centrifuged at 2000 Rp~r for 15 minutes, and the supernatant 
fluid tested for infectivity. This procedure was repeated at irregular intervals. 
In  1 experiment,  infectivity was demonstrated  on the  20th,  40th,  54th,  and 
57th  day.  In  a  2nd  experiment,  the  infectious  titers  were  103, 101, 10  *,  and 
<  101 infectious units per ml on the 7th, 14th, 48th, and 81st days, respectively. 
8.  Failure to demonstrate neutralizing  antibody 
Heat Stable Serum Antibody.--A  large variety of serums was tested for neu- 
tralizing antibody against about 10 infectious doses of this transmissible agent. 
No neutralizing antibody has so far been detected in serums preheated at 56°C 946  CULTURED HUMAN  CELLS 
for 30  minutes. Serums  that have been  tested  thus far are  classified in  the 
following groups: 
1.  Twenty-three convalescent infectious hepatitis sera collected 2 to 3 months 
after onset of jaundice from 3 different outbreaks in Massachusetts in  1954, 
1955, and 1960. 
2.  Three serums collected about 2 months after onset of jaundice from indi- 
viduals  given  the  serum  hepatitis  virus  (kindly furnished by Dr.  Roderick 
Murray). 
3.  Two serums from patients with jaundice due to leptospirosis  (diagnosis 
confirmed by the agglutination-lysis tests). 
4.  Three serums from elderly patients with severe obstructive jaundice. 
5.  Seventeen  convalescent serums  collected from patients  recovered  from 
the following illness: 3 rubella, 2 rubeola, 1 varicella, 2 ECHO-16 exanthema, 
1 mumps, 1 herpetic gingivitis, 1 poliomyelitis, 1 influenza, 1 adeno-3, 2 Rocky 
Mountain spotted fever, and 2 rickettsialpox. 
6.  Human  gamma  globulin  prepared  from  approximately  1000 units  of 
outdate blood collected in Massachusetts  (kindly furnished by Dr.  Geoffrey 
Edsall  of  the  Institute  of Laboratories,  Commonwealth of  Massachusetts). 
This lot of gamma globulin was tested at the concentration of 4 per cent (anti- 
body against 100 IDa0 of poliovirus type 1 was demonstrable at 0.2 per cent). 
7.  Ninety-nine serums from healthy adults who were students or employees 
in the Harvard Medical Area. 
8.  Serums of 3 laboratory personnel working with this agent for 1 or more 
years (tested about every 6 months). 
9.  Seven specimens of human placental cord serums. 
10.  Serums from healthy adults (with or without clinical trachoma) residing 
in  the following localities: 20  from Ethiopia,  10  from Hong Kong,  10 from 
Portugal, and 50 from Yugoslavia. 
11.  Forty-five white Swiss mouse,  19 white rat, 35 cotton rat, 6 rooster,  7 
rabbit,  15 guinea pig, 8 horse, and 2 hamster serums (these were tested indi- 
vidually or in pools of 4 to 10 serums). 
12.  Hyperimmune serums against parainfluenza virus, types 1,  2, and 3. 
13.  One  chimpanzee  serum  with  high  neutralizing  titer  against  the  D.A. 
virus, kindly furnished by Dr. Hsiung (26). 
14.  Two pools of monkey serum and 2 pools of chick plasma. 
Failure  to  Produce  Antibody  in  Rabbits  and  M/ce.--Attempts  to  produce 
antibody have been unsuccessful thus far. The following immunizing procedures 
were used: 
1.  Three rabbits were given weekly intravenous injections of about 2 X  10  6 
specifically involved shrunken "liver" cells  for 3  successive weeks and were 
bled on the 5th and 10th days after the last injection. 
2.  Two  rabbits  were  given  an  intramuscular injection of about  5  X  10  6 R.  SItltlMAN  CHANG  AND  MARYELLEN  ttlYM~ES  947 
specifically involved shrunken "liver" cells suspended in Freund's incomplete 
adjuvant,  and were bled 3  months later. 
3.  One white Swiss mouse was given intravenously 10 to 30 infectious doses 
at each injection for a  total of 11 injections; daily for 3 injections, every 3rd 
day for 3 more injections, every 5th day for another 3 injections, and 2 more 
injections at weekly intervals. Another was similarly treated but by the intra- 
peritoneal route. Serums collected 7 days after the last injection failed to neu- 
tralize  this  transmissible  agent  at  1/4  dilution. 
4.  Eight white Swiss mice were given subcutaneously 2 X  10  e sarcoma 180 
II cells (13) mixed with equal number of specifically involved shrunken "liver" 
cells. 2 months later, they were bled. No neutralizing antibody could be demon- 
strated when tested undiluted. At the time of bleeding, 3 mice developed large 
subcutaneous tumors and 5 were without tumors. From 2 of these tumors, this 
transmissible agent was readily recovered following explanation of the tumors 
in vitro. 
9.  The  existence  of an  ubiquitous  heat-labile  inhibitor  in  serums 
When  the  neutralization  tests  were performed without  the  preheating  of 
test serums, many were found to contain inhibitor against  this transmissible 
agent. Subsequent study showed that this inhibitor was present in almost all 
fresh serums or in those kept frozen at below  -20°C  within 48 hours after 
collection. The activity of this inhibitor may be manifested by a delay in the 
onset of cytopathic changes or complete inactivation of this transmissible agent. 
A total of 76 human and 81 animal serums have been tested. These serums were 
collected by the Staff of this Department and were known to have been stored 
at below  --20°C within 48 hours after collection. The frequency with which 
they had been thawed and refrozen before testing was not known, however. 
The results are summarized in Table V:  this inhibitor is present in at least 
96 per cent of all the serums tested, in human as well as in animal serums, in 
human placental cord as well as human adult serum, and in human serums col- 
lected from Hong Kong, Ethiopia,  as well as those in Boston. The inhibitor 
titers in the hepatitis serums are not any higher than that of the general popu- 
lation.  The placental  cord  and  the  adult  serum  have  comparable inhibitor 
titers. It seems reasonable to conclude that this heat-labile inhibitor is a normal 
serum component. 
Thermostability  of this Inhibitor.--The  stability of this serum inhibitor was 
studied by determining the neutralizing titers of 2 pools of human serums kept 
at 37°C  and at 0-4°C  for varying durations.  The results are summarized in 
Table VI; significant decreases in the inhibitor activity are noted after 4 days 
at 36°C  and 4  weeks at 0--4°C.  Heating at  56°C  for 30 minutes  completely 
eliminates  its  activity.  Repeated  freeze-thawing affects  the  activity  of  one 
pool and not the other. 948  CULTURED  HUMAN  CELLS 
Loss of Activity Following Cold Ethenol Fractionation and Ether Extraction.- 
Two pools of human serums with initial inhibitor titers of 1/4 and 1/16 were 
fractionated into fraction II +III  and II +III  supernate by the cold ethanol 
method (27). Inhibitor activity could not be demonstrated in both fractions 
tested singly or in combination.  Two extractions  with equal portion of ether 
TABLE V 
Titers~Heat-LaMlelnhibitorin  VariousSerums 
Serum 
~uman 
a.  Boston 
i.  Medical students  .... 
ii. Blood  donors. 
iii. Lab personnel. 
Duration of 
storage 
5  yrs. 
2 yrs. 
1 yr. 
No. tested 
I  9 
2 pools of 5 
12 
iv.  Investigators. 
v.  Placental cord 
vi. Hepatitis. 
b.  Hong Kong. 
c. Ethiopia. 
[orse. 
~uinea pig. 
[amster. 
:otton rat 
ghite rat. 
Vhite Swiss mouse. 
',ooster. 
1 yr. 
fresh 
1 wk.  7 
<6 mos.  12 
3 yrs.  10 
2 yrs.  10 
1 wk.  3 
1 wk.  pool of 15 
3 yrs. ?  2 
3 yrs. ?  7 pools of 5 
3 yrs. ?  4 pools of 5 
fresh  2 
3 yrs. ?  1 pool of 4 
No. with titer of 
None  1  4 
2  7 
1  1 
I0 
I 
1?*  5 
2  I0 
2  8 
2  6 
1  l  1 
1 
2 
75 
4~ 
2* 
1 
16 
* Negative at 1/4; quantity insufficient for testing without dilution. 
Negative at 1/4; all pools combined and found positive when tested without dilution. 
for 1 minute each resulted in complete loss of inhibitor activity of both pools 
of serums. 
Presumed Non-Identity  of this  Inhibitor  and  the  Properdin  System.--Heat- 
labile component of normal serum capable of neutralizing certain viruses had 
been reported (28-30, and their references). Subsequent study suggested that 
this normal labile inhibitor against the myxoviruses was identical to the proper- 
din system (31). Experiments were designed to determine if our inhibitor was 
similar  to  the  properdin  system.  The  following results  indicate  their  non- 
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1.  Neutralization at 0-4°C. The properdin system was said to be inactive at 
below 10°C, and the optimal temperature for its action, about 37°C (31).  The 
inhibitor described by us was at least as active at 0-4°C as at 37°C. A pool of 
guinea pig serums and  1 of human serums were titrated for inhibitor against 
this  transmissible  agent.  The interaction of the diluted  serum and the agent 
was allowed to take place for 1 hour at 0°C or at 37°C before inoculation. Titers 
of inhibitor were similar whether the interaction occurred at 0 or at 37°C. 
2.  Neutralization in the presence of sodium citrate. Magnesium and/or cal- 
cium were demonstrated  essential  in  the neutralization  of the myxovirus by 
TABLE VI 
Neutralizing  Titers of 2 Pools* of Human Serum Stored at Different Temperatures 
for Varying Intervals 
Treatment 
None ....................................... 
56°C, 30 rain  ................................ 
Freeze thaws X 10 ........................... 
36°C, 1 day ................................. 
36°C, 2 days  ................................ 
36°C, 4 days ................................ 
0-4°C, 1 wk  ................................ 
0--4°C, 2 wks  ................................ 
0-4°C, 4 wks  ................................ 
Titer of inhlbitor 
Pool A 
4~ 
None§ 
4 
4 
1 
None 
4 
4 
1 
Pool B 
16 
None 
1 
1 
1 
None 
4 
16 
1 
* Both pools have been kept frozen at below -20°C for about 2 years. 
:[: Reciprocal of serum dilution which delayed the onset of degeneration for 3 or more days. 
§ None detectable when serums were tested undiluted. 
the properdin system (28-31). When 1 or 2.5 per cent sodium citrate was used 
in  the diluent,  the neutralizing activity against  the myxovirus was inhibited 
(28,  29).  The presence of 1 per cent sodium citrate in the diluent did not de- 
tectably reduce the inhibitor titers of 2 serums tested. Their titers were 1/8 and 
1/2  when tested  without sodium citrate,  and  1/8 and  1/4 in the presence of 
1 per cent sodium citrate. 
3.  Failure to restore the activity of fraction II -{- III. Properdin was reported 
to be present in Cohn's fraction III or II +III  (32, 33). If the inhibitor against 
this  transmissible  agent  were  the  properdin  system,  one  should  be  able  to 
restore the inhibitory activity of fraction II +III  by the addition of guinea 
pig  complement  and  magnesium ions.  Concentrated fraction  II  q-  III was 
mixed with guinea pig serum, modified Holmes' medium, and the transmissible 
agent. The proportion of each component was such that the final concentrations 950  CULTURED  HUMAN  CELLS 
of fraction II +III  were equivalent to undiluted serum and that of guinea pig 
serum at 1/10 dilution. Mter 1 hour at 37°C, "liver" cultures were inoculated 
with this mixture. Degeneration appeared at about the same time as the control 
containing similar quantities of guinea pig complement and the transmissible 
agent. Two human serum fraction II +III,  kept frozen at --20°C for 2 years, 
have been so tested. The original unfractionated serums,  also kept frozen at 
--20°C  for about  2  years,  were found to inhibit  this  transmissible  agent at 
1/4 and  1/16 dilution. The guinea pig serum, used in this study, hemolyzed 
sensitized sheep erythrocyte at  1/320 and inhibited  this  transmissible  agent 
at 1/4 dilution. Since a  combination of fraction II +III  containing most of 
the properdin, guinea pig complement, and magnesium ions Cwhich constituted 
the properdin system) failed to inactivate this transmissible agent, this may be 
considered additional  evidence of  the  non-identity of  these  two  heat-labile 
inhibitors. 
Reactivation  of the  Agent  Treated  with  Serum  Inhibitor.--To  elucidate  the 
mechanism of this inactivating process, attempts were made to reactivate this 
agent  previously inactivated  by  the  serum  inhibitor.  We  have  found  that 
reactivation may be readily accomplished through simple solution as illustrated 
by the following experiment: 
0.2 ml of a  preparation of this  agent  (-4- 100 infectious doses)  was mixed 
with 0.4 ml of serum. The mixture was kept at 0-4°C for 24 hours and then 
divided into 2 equal portions.  1 of the portions was kept at 0-4°C for another 
48 hours and  then inoculated into a  "liver" culture. The other portion was 
diluted to 10 ml with modified Holmes' medium, kept at 0-4°C for 24 hours, 
and centrifuged at 14,000 m~ for 1 hour in a Servall SS-1 angle head centrifuge. 
The upper 9 ml was discarded. The lower 1 ml was diluted to 10 ml with modi- 
fied Holmes' medium, kept at 0-4°C for 24 hours,  and centrifuged at  14,000 
RPM again for 1 hour. The lower 1 ml together with whatever sediment that 
may be present was transferred to a  "liver" culture. The cultures were then 
observed for the appearance of characteristic degeneration. 
The results are shown in Table VII which is seif-explanatory. These results 
suggest  that  the  inactivation  of  this  transmissible  agent  by the  heat-labile 
serum inhibitor is due to some non-specific complexing of the agent and in- 
hibitor  rather  than  due  to  enzymatic degradation.  The  dissociation  of  the 
agent-inhibitor complex in the presence of magnesium ion is also contrary to 
that reported for the dissociation of myxovirus-properdin complex (22,  25). 
10.  Failure to reisolate a similar agent 
Our failure to reisolate a similar agent from the original frozen blood speci- 
mens was reported previously (1). It was suggested then that (since this trans- 
missible  agent was unstable  to freeze-thawing)  isolation attempts  should  be 
made with fresh hepatitis blood. To date, we have inoculated "liver" cultures R. SID'WM'AN CHANG  AND MARYELLEN  tt-0"MES  951 
with  over  35  specimens  of  fresh  blood  collected  from  infectious  hepatitis 
patients during the 1st or 2nd week of jaundice. These cultures were observed 
for 3 to 5 weeks with no evidence of progressive degeneration. 1 blind passage 
was routinely made and the culture was observed for another 3  to 5  weeks; 
again, no progressive degeneration appeared. In several instances, 3 or 4 blind 
passages were made before the cultures were discarded as negative. 
It is conceivable that our failure to reisolate this  transmissible agent from 
fresh hepatitis bloods may be due to its complexing with the ubiquitous serum 
inhibitor.  Since this complexing of agent and inhibitor may be readily disso- 
ciated by simple dilution (see section on reactivation), seventeen frozen hepa- 
titis bloods were subjected to the dilution process prior to inoculation of the 
TABLE VII 
Reactivation o/Infectivity of Serum Inactivated Agent by Simple Dilution 
Exp.  Infectious  agent mixed with 
Holmes' medium 
Guinea pig serum pool 
Normal human serum pool 
Holmes' medium 
Hepatitis serum A 
Hepatitis serum B 
CPE in culture-receiving 
mixture treated by 
Dilution  No treatment 
5*  5 
5  17 
5  Neg. 
5  5 
5  11 
5  Neg. 
* Number of days after inoculation when characteristic cytopathic changes appeared; 
negative indicated absence of degeneration after 21 days. 
"liver" and the primary human amnion cultures. Again, no transmissible cyto- 
pathic agent could be demonstrated in cultures observed for at least 2 months 
after receiving such materials. Owing to shortage of available clinical materials, 
we have not yet tested any fresh hepatitis bloods which are subjected to this 
dilution process before inoculation into cell cultures. 
11.  Other miscellaneous observations 
Similar to the cell-associated forms (1), 3 to 10 infectious doses of the cell- 
free form,  given intracerebrally or  intraperitoneally, failed  to  produce  any 
overt disease in white Swiss mice (1 to 3-day-old) during observation periods 
of 3 weeks. About 100 infectious doses given by the amniotic route to 7-day-old 
chick embryo failed to increase significantly the embryonic mortality. Prepa- 
rations containing about 108 infectious doses per ml failed to hemagglutinate 
human group O or embryonic chick erythrocytes at 0--4°C. Partially degener- 
ated "liver" or primary human amnion cultures (known to be releasing infec- 952  CULTURED  HUMAN  CELLS 
tious materials) did not hemadsorb human group O or embryonic chick ery- 
throcytes. No visible growth can be detected after cultivation on beef infusion 
agar containing 10 per cent fresh horse blood or serum-agar medium for pleuro- 
pneumonia-like organisms (34);  these cultures were kept for 7 days at 36°C in 
an atmosphere of 5 per cent CO2 in air. 
DISCUSSION 
Data presented suggest that this transmissible agent is a virus consisting of 
DNA protected by a surface coat rich in lipids. Since many of its unusual char- 
acteristics can best be explained by a hypothesis that its outmost surface con- 
sists chiefly of lipids, we would like to propose that this agent be referred to 
tentatively as a lipovirus. 
The suppressive action of 5-fluorodeoxyuridine on the formation of this virus 
in primary human amnion, liver, and conjunctival cells indicates that DNA is 
an essential component. This line of reasoning is somewhat weakened by our 
failure to  obtain regular  and complete reversal  of  this  suppressive  action of 
FUDR  by thymidine or  thymidylate. There  has  been,  as  yet,  no  reported 
exception to the finding that FUDR suppresses the synthesis of DNA but not 
RNA viruses in mammalian cells.  The failure of thymidine and/or uracil to 
reverse the suppression of the formation of this virus by FUDR may be con- 
sidered a  characteristic so far unique to this lipovirus. 
Our contention that its surface coat consists chiefly of lipids is based on the 
following findings: 1. the complete inactivation by ether and chloroform, and 
partial reduction of infectivity by sodium deoxycholate; 2.  the slow inactiva- 
tion by 0.025 per cent formalin; 3. the reversible complexing with an ubiquitous 
serum inhibitor, presumably lipoprotein-like; 4. the retention of infectivity by 
membrane filter (Millipore) with pore size of 5 microns; 5. the inactivation by 
freeze-thawing in contrast to its marked stability at 0-4°C; 6.  the failure of 
DNAse,  RNAse,  trypsin,  papain,  lysozyme, hyaluronidase, lecithinase,  and 
pancreatic  lipase  to  reduce  significantly its  infectivity, and  7.  its  apparent 
immunological non-reactiveness. 
The  failure  of  lecithinase and  lipase  to  inactivate  this  lipovirus  appears 
paradoxical. This, however, may be explained on the basis of high substract 
specificity and our inability to provide optimal conditions for lipolysis. 
The statement that the lipovirus is apparently non-reactive immunologically 
is based on the following two observations: 1. our failure to demonstrate heat- 
stable neutralizing antibody in a  large variety of human and animal serums, 
and in human gamma globulin; and 2. our inability to elicit an immunological 
response in rabbits and mice. 
It should be emphasized that the failure to elicit antibody response by the 
methods used may also be due to our inability to give sufficient quantity of 
antigenic materials. We have tried to overcome this difficulty.by creating sar- R. SIJIHMAN CHANG  AND  MARYELLEN  HUMES  953 
comas in the white Swiss mice with sarcoma 180 cells of Foley (13),  infecting 
the sarcoma 180 cells with this agent, demonstrating the presence of this agent 
in the sarcoma 2 months after infection, and then testing for antibody in the 
serums of these mice. None were demonstrated. While it is reasonable to con- 
clude that limited multiplication of this agent had taken place in the sarcoma- 
bearing mice, the possibility that the agent existed in latent forms cannot be 
excluded. Inability to obtain satisfactory immune response in the laboratory 
animals has been reported for the cytomegalovirus (35). Antibody to the cyto- 
megalovirus, however, can be readily demonstrated in humans (35). The possi- 
bility that our serological survey is not sufficiently exhaustive or method not 
sufficiently sensitive to detect a very low incidence of antibody should also be 
mentioned. 
The  susceptibility of  sarcoma  180  cells  in  ~itro (completely destroyed in 
2 to 3 days by the dose of specifically involved shrunken cells used) in contrast 
to the markedly reduced susceptibility when transplanted in  vivo (cells  con- 
tinued to divide forming large sarcoma in 2 months) is an observation of some 
interest.  Similarly, explants of chick embryonic tissues were completely de- 
stroyed while chick embryos survived infection ~/a the yolk sac or amniotic 
routes. Differences in the in ~itro and in ~ivo susceptibility of tissues to polio- 
virus and myxoma viruses have been described (36-38). Little is known, how- 
ever, about the basic mechanism of the reduced in ~vo susceptibility of certain 
tissues to these viruses. 
The nature of the ubiquitous inhibitor against this transmissible agent de- 
serves discussion. It is presumably a  normal component of most mammalian 
serum since it is present in at least 96 per cent of the 157 serums tested, and 
since comparable quantity (1/1 to 1/16)  was found in human placental cord 
serums as in serums collected from the adult populations. The evidence pre- 
sented appeared sufficient to conclude that this inhibitor is not the properdin 
system. Its instability to heating at 56°C,  to storage at 37°C,  or 0--4°C, to 
repeated freeze-thawing, to ether extraction, and to cold ethenol fractionation 
suggests the possibility that this inhibitor is a lipoprotein. The mechanism of 
this reversible complexing of an agent rich in surface lipids and a lipoprotein 
may be similar to that described by Younger and Noll (39). The role of such an 
inhibitor in the defense mechanism of an organism against infection by this 
transmissible agent is not known at the present time. It is not difficult, how- 
ever, to visualize its role in limiting hematogeneous dissemination of infectious 
processes. It is possible that a  transient or prolonged deficiency in this llpo- 
protein inhibitor may impair the barrier against infection by this agent. We 
are not certain whether the failure to detect this inhibitor in a few of the 157 
serums tested was representative of such a deficiency or the result of excessive 
freeze-thawing which many of these serums may have been  subjected  to. 
The origin of this transmissible agent remains obscure. Although it presum- 954  CIYLTURED  HUMAN" CELLS 
ably originated from blood taken from an infectious hepatitis patient during 
the acute phase,  we have not been able to reisolate a  similar agent  (or any 
transmissible cytopathic agent) from the bloods of 43 infectious hepatitis pa- 
tients collected in  1954, 1955, and  1960. The possibilities  that  this  agent is 
indigenous in the "liver" culture or that it had been introduced inadvertently 
from an extraneous source should be considered. We have not been able, how- 
aver, to induce the appearance of a similar agent from uninfected culture, or to 
define the extraneous source.  The data presented appear  sufficient for us  to 
conclude that this is a new transmissible agent not described previously. The 
characteristic cytopathology and the unique property of thymine degradation 
(4) rule out the possibility that the lipovirus is a common virus which has lost 
its ability to synthesize immunologically reactive coat. 
The existence of a viral agent with immunologically non-reactive coat may 
provide attractive  explanations for some of the immunological anomalies in 
infectious diseases.  The inactivation of an immunologically non-reactive virus 
by an ubiquitous serum component may provide basis for hypothesizing the 
existence of a  new  type of defense mechanism.  We feel, however,  that  our 
present findings are inadequate in establishing any clinical role of this agent 
and that further study is required to  establish conclusively its immunologic 
non-reactiveness. The possible existence of infectious nucleic acids wrapped in 
lipid coats has been discussed in a recent article by Herriott (40). 
SUMMARY 
Experiments  designed to  characterize  an  unidentified  transmissible  agent 
brought forth the following findings: 
The cytopathology consisted of the formation of intranuclear globules, col- 
lapse of the involved nuclei, and the extrusion of nuclear materials. 
The relatively dormant primary human amnion cells  were less  susceptible 
than the rapidly growing cell  lines.  Similarly, the slowly multiplying ribose 
variants were less  susceptible than their corresponding parent cell lines. 
Interferon-like activity was released from infected cells. 
Infectivity was readily demonstrated following storage at 0-4°C for at least 
8 months or at 37°C for at least 2 weeks. Freeze-thawing, however, markedly 
reduced or completely destroyed its infectivity. 
Infectivity was destroyed completely by ether and chloroform; partially by 
desoxycholate, and  not  affected by  trypsin,  papain,  RNAse,  DNAse,  hyal- 
uronidase, lysozyme, lecithinase, or pancreatic lipase. 
The rate of inactivation by 0.025  per cent formalin was much slower than 
that of vaccinia and herpes viruses. 
Its synthesis was suppressed by 5-fluorodeoxyuridine. This suppression was 
not reversed by thymidine and/or  uracil. 
Heat-stable neutralizing antibody could not be demonstrated in 379 human R. SHIIIMAN CHANG  AND  MARMELLEN  HUM~S  955 
and  animal  serums, in human  gamma  globulins,  or in  serums from animals 
"immunized" with this agent. 
Heat-labile  inhibitors  (lipoprotein-like) capable of inhibiting the infectivity 
of this agent were demonstrated in 154 of the 157 serums tested. 
Experimental evidence indicated the non-identity of this ubiquitous inhibitor 
and the properdin system. 
The non-infectious complex between this  agent and the ubiquitous  serum 
inhibitor may be dissociated (hence, become infectious) by simple dilution. 
Repeated attempts to reisolate a similar agent have not been successful. 
We have hypothesized that this agent is a virus consisting of DNA wrapped 
in a surface coat rich in lipid,  and suggest that this virus be referred to tenta- 
tively as a lipovirus. 
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EXPLANATION OF  PLATES 
PLATE 102 
FI6. 1.  Cytopathology in  unstained  liver  cultures,  X  100. 
(A) uninfected control, (B) partial degeneration, and (C) complete degeneration. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 115  PLATE  102 
(Chang and Humes: Cultured human cells) PLATE 103 
FIG.  2.  Cytopathology  in  liver  cultures  stained  with  hematoxylin-eosin  and 
magnified  X  400. 
(A)  basophilic  globules  in  nuclei,  (B)  "collapse"  of involved  nuclei,  (C)  partial 
extrusion  of nuclear  materials,  and  (D)  end  stage  consisting of a  "shrunken"  cell. 
See text also. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 115  PLATE  103 
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